Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplant

Gonadal impairment is an important late effect with a significant impact on quality of life of transplanted patients. The aim of this study was to compare gonadal function after busulfan (Bu) or treosulfan (Treo) conditioning regimens in pre- and postpubertal children. This retrospective, multicente...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Faraci, Maura (VerfasserIn) , Dreger, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 11 May 2019
In: Biology of blood and marrow transplantation
Year: 2019, Jahrgang: 25, Heft: 9, Pages: 1786-1791
ISSN:1523-6536
DOI:10.1016/j.bbmt.2019.05.005
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.bbmt.2019.05.005
Verlag: http://www.sciencedirect.com/science/article/pii/S1083879119302897
Volltext
Verfasserangaben:Maura Faraci, Tamara Diesch, Myriam Labopin, Arnaud Dalissier, Arian Lankester, Andrew Gennery, Mikael Sundin, Duygu Uckan-Cetinkaya, Marc Bierings, Anke M. J. Peters, Martina Garwer, Ansgar Schulz, Gerard Michel, Giovanna Giorgiani, Bernd Gruhn, Franco Locatelli, Stefano Giardino, Anne Uyttebroeck, Fanny Rialland, Maija Itäla-Remes, Peter Dreger, Peter J. Shaw, Victoria Bordon, Paul G. Schlegel, Karin Mellgren, Jose M. Moraleda, Katharine Patrick, Pascale Schneider, Charlotte Jubert, Anita Lawitschka, Nina Salooja, Grzegorz W. Basak, Selim Corbacioglu, Rafael Duarte, Peter Bader, on behalfof the Pediatric and Transplant Complications Working Parties of the European Society for Blood and Marrow Transplantation

MARC

LEADER 00000caa a2200000 c 4500
001 1684960363
003 DE-627
005 20220817180859.0
007 cr uuu---uuuuu
008 191210s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.bbmt.2019.05.005  |2 doi 
035 |a (DE-627)1684960363 
035 |a (DE-599)KXP1684960363 
035 |a (OCoLC)1341280841 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Faraci, Maura  |e VerfasserIn  |0 (DE-588)1201385369  |0 (DE-627)1684962277  |4 aut 
245 1 0 |a Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplant  |c Maura Faraci, Tamara Diesch, Myriam Labopin, Arnaud Dalissier, Arian Lankester, Andrew Gennery, Mikael Sundin, Duygu Uckan-Cetinkaya, Marc Bierings, Anke M. J. Peters, Martina Garwer, Ansgar Schulz, Gerard Michel, Giovanna Giorgiani, Bernd Gruhn, Franco Locatelli, Stefano Giardino, Anne Uyttebroeck, Fanny Rialland, Maija Itäla-Remes, Peter Dreger, Peter J. Shaw, Victoria Bordon, Paul G. Schlegel, Karin Mellgren, Jose M. Moraleda, Katharine Patrick, Pascale Schneider, Charlotte Jubert, Anita Lawitschka, Nina Salooja, Grzegorz W. Basak, Selim Corbacioglu, Rafael Duarte, Peter Bader, on behalfof the Pediatric and Transplant Complications Working Parties of the European Society for Blood and Marrow Transplantation 
264 1 |c 11 May 2019 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.12.2019 
520 |a Gonadal impairment is an important late effect with a significant impact on quality of life of transplanted patients. The aim of this study was to compare gonadal function after busulfan (Bu) or treosulfan (Treo) conditioning regimens in pre- and postpubertal children. This retrospective, multicenter study included children transplanted in pediatric European Society for Blood and Marrow Transplantation (EBMT) centers between 1992 and 2012 who did not receive gonadotoxic chemoradiotherapy before the transplant. We evaluated 137 patients transplanted in 25 pediatric EBMT centers. Median age at transplant was 11.04 years (range, 5 to 18); 89 patients were boys and 48 girls. Eighty-nine patients were prepubertal at transplant and 48 postpubertal. One hundred eighteen children received Bu and 19 Treo. A higher proportion of girls treated with Treo in the prepubertal stage reached spontaneous puberty compared with those treated with Bu (P=.02). Spontaneous menarche was more frequent after Treo than after Bu (P < .001). Postpubertal boys and girls treated with Treo had significantly lower luteinizing hormone levels (P=.03 and P=.04, respectively) compared with the Bu group. Frequency of gonadal damage associated with Treo was significantly lower than that observed after Bu. These results need to be confirmed in a larger population. 
650 4 |a Busulfan 
650 4 |a Gonadal damage 
650 4 |a Pubertal stage 
650 4 |a Treosulfan 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
773 0 8 |i Enthalten in  |t Biology of blood and marrow transplantation  |d [Erscheinungsort nicht ermittelbar] : Elsevier Health Sciences, 1998  |g 25(2019), 9, Seite 1786-1791  |h Online-Ressource  |w (DE-627)334374782  |w (DE-600)2057605-5  |w (DE-576)118352229  |x 1523-6536  |7 nnas  |a Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplant 
773 1 8 |g volume:25  |g year:2019  |g number:9  |g pages:1786-1791  |g extent:6  |a Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplant 
856 4 0 |u https://doi.org/10.1016/j.bbmt.2019.05.005  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1083879119302897  |x Verlag 
951 |a AR 
992 |a 20191210 
993 |a Article 
994 |a 2019 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 21 
999 |a KXP-PPN1684960363  |e 356291296X 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 10.12.2019"],"relHost":[{"origin":[{"publisher":"Elsevier Health Sciences ; Carden Jennings","dateIssuedDisp":"[1998-2020]","publisherPlace":"[Erscheinungsort nicht ermittelbar] ; Charlottesville, Va."}],"recId":"334374782","type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"BBMT"}],"note":["Gesehen am 16.03.2021"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplantBiology of blood and marrow transplantation","id":{"issn":["1523-6536"],"zdb":["2057605-5"],"eki":["334374782"]},"part":{"pages":"1786-1791","extent":"6","issue":"9","volume":"25","year":"2019","text":"25(2019), 9, Seite 1786-1791"},"language":["eng"],"title":[{"title":"Biology of blood and marrow transplantation","subtitle":"BBMT ; the official journal of the American Society for Blood and Marrow Transplantation","title_sort":"Biology of blood and marrow transplantation"}],"pubHistory":["Volume 4, issue 1 (June 1998)-Volume 26, issue 12 (December 2020)"]}],"id":{"eki":["1684960363"],"doi":["10.1016/j.bbmt.2019.05.005"]},"physDesc":[{"extent":"6 S."}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"11 May 2019"}],"recId":"1684960363","type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"family":"Faraci","display":"Faraci, Maura","given":"Maura","role":"aut"},{"family":"Dreger","display":"Dreger, Peter","given":"Peter","role":"aut"}],"name":{"displayForm":["Maura Faraci, Tamara Diesch, Myriam Labopin, Arnaud Dalissier, Arian Lankester, Andrew Gennery, Mikael Sundin, Duygu Uckan-Cetinkaya, Marc Bierings, Anke M. J. Peters, Martina Garwer, Ansgar Schulz, Gerard Michel, Giovanna Giorgiani, Bernd Gruhn, Franco Locatelli, Stefano Giardino, Anne Uyttebroeck, Fanny Rialland, Maija Itäla-Remes, Peter Dreger, Peter J. Shaw, Victoria Bordon, Paul G. Schlegel, Karin Mellgren, Jose M. Moraleda, Katharine Patrick, Pascale Schneider, Charlotte Jubert, Anita Lawitschka, Nina Salooja, Grzegorz W. Basak, Selim Corbacioglu, Rafael Duarte, Peter Bader, on behalfof the Pediatric and Transplant Complications Working Parties of the European Society for Blood and Marrow Transplantation"]},"language":["eng"],"title":[{"title":"Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplant","title_sort":"Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplant"}]} 
SRT |a FARACIMAURGONADALFUN1120